Posted by Squiggles on February 27, 2007, at 16:07:55
In reply to Re: Drug manufacturing and quality control » notfred, posted by Larry Hoover on February 27, 2007, at 15:34:48
I propose that BA is easier to botch, and get away with, as many environmental circumstances, such as storage, temperature, age an be overlooked. And I would guess that when there are problems between generics and trade variations, it is not the bioequivalence that has not passed the test but the bioavailability.
Squiggles
poster:Squiggles
thread:735309
URL: http://www.dr-bob.org/babble/20070224/msgs/736838.html